Evidence map›Paper›PMID 30479641›Full record

ArticleImmunity & ageing : I & A2018

Effects of chocolate containing

Reiko Kuroda, Hiroaki Higuchi, Keishirou Yoshida, Yasunori Yonejima, Keiko Hisa, Masanori Utsuyama, Kenji Osawa, Katsuiku Hirokawa

Abstract read
In one paragraph

Article in Immunity & ageing : I & A, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Review
  3. Stimulatory Effects of Extracellular Vesicles Derived fromCurrent issues in molecular biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Reiko KurodaCentral Laboratory, LOTTE Co., Ltd., 1-1, Numakage 3-chome, Minami-ku, Saitama, 336-8601 Japan.
Hiroaki HiguchiCentral Laboratory, LOTTE Co., Ltd., 1-1, Numakage 3-chome, Minami-ku, Saitama, 336-8601 Japan.
Keishirou YoshidaCentral Laboratory, LOTTE Co., Ltd., 1-1, Numakage 3-chome, Minami-ku, Saitama, 336-8601 Japan.
Yasunori YonejimaNitto Pharmaceutical Industries, Ltd., 35-3, Minamibiraki, Kamiueno-cho, Muko, Kyoto, 617-0006 Japan.
Keiko HisaNitto Pharmaceutical Industries, Ltd., 35-3, Minamibiraki, Kamiueno-cho, Muko, Kyoto, 617-0006 Japan.
Masanori Utsuyama3Institute for Health and Life Science, Tokyo Medical & Dental University, 3-10, Kandasurugadai 10-chome, Chiyoda-ku, Tokyo, 101-0062 Japan.
Kenji OsawaCentral Laboratory, LOTTE Co., Ltd., 1-1, Numakage 3-chome, Minami-ku, Saitama, 336-8601 Japan.
Katsuiku Hirokawa3Institute for Health and Life Science, Tokyo Medical & Dental University, 3-10, Kandasurugadai 10-chome, Chiyoda-ku, Tokyo, 101-0062 Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious reports showed that oral administration of

methodsParticipants (mean age: 46.3 years) ingested 28 g of test food daily, at a time of their own choice, for 4 weeks. The immunological parameters of all participants were evaluated two times (pre- and post- ingestion). At the end of the study, various immunological parameters of the participants were measured and scoring of immunological vigor (SIV) was performed using a comprehensive algorithm.

resultsIngestion of NTM048-supplemented chocolate significantly improved SIV in the NTM048 group (18.6 ± 1.6) compared to that in the placebo group (17.8 ± 2.0) after 4 weeks (

conclusionOur results suggest that ingestion of chocolate supplemented with NTM048 is effective against the age-related decline in T cell-related immune functions.

trial registrationUMIN Clinical Trials Registry UMIN000021989. Registered 19 April 2016, https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025321.

Indexed as

ChocolateImmunological parametersLeuconostoc mesenteroides strain NTM048Randomized controlled trialScoring of immunological vigor

Identifiers

PMID30479641
PMCPMC6247524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.